Schedule 13G ownership disclosure
ACURA PHARMACEUTICALS, INC
Security class unavailable · CUSIP: 00509L703
Event date: 2015-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 727,867
- Percent of class
- 6.1700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535610-16-000124
- Form type
- SC 13G
- Filer
- ACURA PHARMACEUTICALS, INC
- CIK
- CIK 786947
- Filed
- Jan 13, 2016
- Reporting period
- Dec 31, 2015
- Description
- Schedule 13G beneficial ownership